Integrating Biomarkers and Guideline-Aligned Treatment Approaches Into Patient-Centered Care for Advanced/Metastatic Endometrial Cancer
Integrating Biomarkers and Guideline-Aligned Treatment Approaches Into Patient-Centered Care for Advanced/Metastatic Endometrial Cancer is organized by Prime Education, LLC.
Release Date: May 19, 2023
Expiration Date: May 18, 2024
Description:
Join us for an exciting discussion on the latest clinical evidence and management strategies for advanced/metastatic endometrial cancer!
During this webcast, expert faculty discuss biomarkers to guide treatment selection, the latest clinical evidence, updated guideline recommendations, strategies for managing adverse events, and patient-centered care for patients with endometrial cancer.
Agenda:
• Differentiating Novel Treatment Approaches for Endometrial Cancer Based on Biomarkers, Mechanism of Action, Safety, Efficacy, and Approved Indications
• Managing Adverse Events Associated With Novel Treatments in Advanced Endometrial Cancer
• Interprofessional Strategies for Quality Patient-Centered Care and Shared Decision-Making, to Optimize Outcomes for Patients With Advanced/Metastatic Endometrial Cancer
Learning Objectives:
• Differentiate novel therapies for endometrial cancer based on biomarkers, mechanism of action, placement in treatment, safety, and efficacy
• Develop evidence-based strategies for monitoring and mitigating adverse effects of novel therapies and combination approaches for endometrial cancer
• Employ evidence-based strategies for quality patient-centered care to optimize outcomes for patients with endometrial cancer.